Litigation

Recent Posts

Ex-GSK General Counsel Acquitted By Judge Of Obstructing FDA Investigation
Posted on 10 May 2011 by Tom Moylan

GREENBELT, Md. - (Mealey's) Former GlaxoSmithKline vice president and associate general counsel Lauren Stevens was acquitted by directed verdict May 10 of charges of obstructing a Food and Drug Administration investigation into the off-label promotion... Read More

Tags: drug Wellbutrin , Lauren Stevens , (United States of America v. Lauren Stevens , off-label promotion , Food and Drug Administration , FDA , Litigation , GlaxoSmithKline , verdict , antidepressant

$2.36B Glaxo Charge Covers Avandia, Paxil Litigation, Other Legal Costs
Posted on 15 Jul 2010 by Tom Moylan

LONDON - (Mealey's) GlaxoSmithKline PLC (GSK) on July 15 said it expects to take a $2.36 billion charge against earnings to settle several legal issues, including settling "the substantial majority" of Avandia product liability cases and... Read More

Tags: diabetes drug , Mealey’s , drugs , drugs & devices , U.S. Securities and Exchange Commission , personal injury , Paxil , paroxetine , product liability , Apotex , Litigation , GSK , GlaxoSmithKline , lawsuit , Glaxo , antidepressant , torts , Avandia

Zoloft Birth Defects MDL Created, Assigned To Eastern District Of Pennsylvania
Posted on 17 Apr 2012 by Tom Moylan

WASHINGTON, D.C. - (Mealey's) More than 92 federal lawsuits alleging birth defects caused by the antidepressant Zoloft and its generic version sertraline were centralized April 17 before Judge Cynthia M. Rufe in the U.S. District Court for the Eastern... Read More

Tags: In Re: Zoloft [Sertraline Hydrochloride] Products Liability Litigation , Judicial Panel on Multidistrict Litigation , Zoloft , birth defects , MDL No. 2342 , JPMDL , Pfizer , Litigation , multidistrict litigation , sertraline , antidepressant , Greenstone LLC

Glaxo Takes $2.36 Billion Charge On Legal Costs
Posted on 15 Jul 2010 by LexisNexis Litigation Resource Community Staff

LONDON - (AP) Pharmaceutical company GlaxoSmithKline said Thursday it expects to take a $2.36 billion charge against second-quarter earnings for the costs of settling court cases over the antidepressant Paxil and diabetes drug Avandia. The company said... Read More

Tags: diabetes drug , European Medicines Agency , birth defects , Paxil , settlements , U.S. Food and Drug Administration , Apotex , Litigation , GSK , GlaxoSmithKline , lawsuit , pharmaceutical , antidepressant , Avandia

Glaxo Settles Bad Drug Claim For More Than $40 Million
Posted on 24 Jun 2011 by LexisNexis Litigation Resource Community Staff

PROVIDENCE, R.I. - (AP) The American subsidiary of a major British drug maker, GlaxoSmithKline LLC, has agreed to pay more than $40 million to 37 states and Washington, D.C., to settle complaints alleging manufacturing process issues at a now-shuttered... Read More

Tags: diabetes drug , drugs , SB Pharmco , health care , Food and Drug Administration , anti-nausea drug , Paxil , drug maker , Bactroban , Cidra , Medicaid , Avandamet , Litigation , GlaxoSmithKline , antibiotic , antidepressant , Puerto Rico , Kytril